129 related articles for article (PubMed ID: 8654608)
1. A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer.
Schumacher U; Horny HP; Horst HA; Herrlich P; Kaiserling E
Eur J Surg Oncol; 1996 Jun; 22(3):259-61. PubMed ID: 8654608
[TBL] [Abstract][Full Text] [Related]
2. CD44 variant exon epitopes in primary breast cancer and length of survival.
Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P
Lancet; 1995 Mar; 345(8950):615-9. PubMed ID: 7534855
[TBL] [Abstract][Full Text] [Related]
3. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
[TBL] [Abstract][Full Text] [Related]
4. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.
Dall P; Heider KH; Sinn HP; Skroch-Angel P; Adolf G; Kaufmann M; Herrlich P; Ponta H
Int J Cancer; 1995 Feb; 60(4):471-7. PubMed ID: 7530237
[TBL] [Abstract][Full Text] [Related]
5. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
[TBL] [Abstract][Full Text] [Related]
6. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of CD44 splice variants in human stage III cervical cancer.
Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of CD44 variant expression in primary breast cancer.
Foekens JA; Dall P; Klijn JG; Skroch-Angel P; Claassen CJ; Look MP; Ponta H; Van Putten WL; Herrlich P; Henzen-Logmans SC
Int J Cancer; 1999 Jun; 84(3):209-15. PubMed ID: 10371335
[TBL] [Abstract][Full Text] [Related]
9. Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters.
Regidor PA; Callies R; Regidor M; Günthert U; Zöller M; Schindler AE
Arch Gynecol Obstet; 1996; 258(3):125-35. PubMed ID: 8781700
[TBL] [Abstract][Full Text] [Related]
10. CD44 in colon cancer.
Herrlich P; Pals S; Ponta H
Eur J Cancer; 1995; 31A(7-8):1110-2. PubMed ID: 7577002
[TBL] [Abstract][Full Text] [Related]
11. CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma.
Guriec N; Marcellin L; Gairard B; Caldéroli H; Wilk A; Renaud R; Bergerat JP; Oberling F
Clin Exp Metastasis; 1996 Oct; 14(5):434-9. PubMed ID: 8871537
[TBL] [Abstract][Full Text] [Related]
12. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
[TBL] [Abstract][Full Text] [Related]
13. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
[TBL] [Abstract][Full Text] [Related]
14. [Expression of CD44 variant v6 in breast carcinoma and its relationship with other parameters of tumor biology].
Aceituno E; Turrión F; San Román JM; Sarasa JL; Ortiz F; García R
Med Clin (Barc); 1998 Jul; 111(5):168-71. PubMed ID: 9732832
[TBL] [Abstract][Full Text] [Related]
15. CD44 splice variants as prognostic markers in colorectal cancer.
Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
[TBL] [Abstract][Full Text] [Related]
16. Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.
Zheng Z; Shao N; Weng H; Li W; Zhang J; Zhang L; Yang L; Ye S
Med Oncol; 2015 Jan; 32(1):275. PubMed ID: 25429827
[TBL] [Abstract][Full Text] [Related]
17. Splice variants of CD44 in human cervical cancer stage IB to IIB.
Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.
Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C
Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of the human CD44 gene in early colorectal malignancy with special reference to variant exon 9 (9v).
Kawahara K; Yoshino T; Kawasaki N; Miyake K; Akagi T
J Clin Pathol; 1996 Jun; 49(6):478-81. PubMed ID: 8763262
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
Bendall LJ; Bradstock KF; Gottlieb DJ
Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
